Skip to main content

EQUIFAX INC

For the period ended Sep 30, 2025. Filed Oct 21, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Oct 21, 2025

EFX$188.33-0.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Consolidated Balance Sheets—

(In millions, except par values)September 30, 2025December 31, 2024
ASSETS
Current assets:
Cash and cash equivalents$189.0$169.9
Trade accounts receivable, net of allowance for doubtful accounts of $19.3 and $16.9 at September 30, 2025 and December 31, 2024, respectively1,015.0957.6
Prepaid expenses143.0134.9
Other current assets116.198.2
Total current assets1,463.11,360.6
Property and equipment:
Capitalized internal-use software and system costs3,003.32,817.5
Data processing equipment and furniture244.7229.6
Land, buildings and improvements290.1285.0
Total property and equipment3,538.13,332.1
Less accumulated depreciation and amortization(1,621.6)(1,440.2)
Total property and equipment, net1,916.51,891.9
Goodwill6,664.76,547.8
Indefinite-lived intangible assets94.794.7
Purchased intangible assets, net1,368.51,521.0
Other assets, net324.3343.4
Total assets$11,831.8$11,759.4
LIABILITIES AND EQUITY
Current liabilities:
Short-term debt and current maturities of long-term debt$759.3$687.7
Accounts payable156.2138.2
Accrued expenses298.7251.1
Accrued salaries and bonuses245.4215.8
Deferred revenue110.5115.5
Other current liabilities413.4403.2
Total current liabilities1,983.51,811.5
Long-term debt4,053.84,322.8
Deferred income tax liabilities, net376.4351.6
Long-term pension and other postretirement benefit liabilities104.4106.7
Other long-term liabilities237.9247.2
Total liabilities6,756.06,839.8
Commitments and Contingencies (see Note 6)
Redeemable noncontrolling interests118.6105.2
Equifax shareholders' equity:
Preferred stock, $0.01 par value: Authorized shares - 10.0; Issued shares - none——
Common stock, $1.25 par value: Authorized shares - 300.0;Issued shares - 189.3 at September 30, 2025 and December 31, 2024;Outstanding shares - 122.6 and 124.0 at September 30, 2025 and December 31, 2024, respectively236.6236.6
Paid-in capital2,003.21,915.2
Retained earnings6,330.36,018.6
Accumulated other comprehensive loss(551.3)(722.7)
Treasury stock, at cost, 66.1 shares and 64.7 shares at September 30, 2025 and December 31, 2024, respectively(3,074.4)(2,644.9)
Stock held by employee benefits trusts, at cost, 0.6 shares at September 30, 2025 and December 31, 2024(5.9)(5.9)
Total Equifax shareholders’ equity4,938.54,796.9
Noncontrolling interests18.717.5
Total shareholders' equity4,957.24,814.4
Total liabilities, redeemable noncontrolling interests, and shareholders' equity$11,831.8$11,759.4
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.